Overview
Comprehensive Strategies to Improve Clinical Outcomes in Heart Failure
Click the"View Activity" button to view this activity.
View ActivityCME/CE is no longer available for this activity
This enduring webcast features an expert panel of three faculty members who will participate in an interactive discussion that will integrate problem-based learning with evidence-based medicine to help incorporate newly issued guideline updates into clinical practice. Panel sessions and audience participation will help to highlight how medical therapies may be combined with devices, and how post-hospital discharge strategies may be optimized, in order to improve patient outcomes in heart failure.
This webcast shares a filmed symposium from the CRT Conference in Washington, DC in February 2017.
This webcast shares a filmed symposium from the CRT Conference in Washington, DC in February 2017.
This educational activity is designed for interventional cardiologists, cardiologists, vascular surgeons, cardiothoracic surgeons, technologists, and nurses involved in the care and treatment of patients with heart failure.
Heart failure (HF) affects 5.7 million adults in the US and its prevalence is predicted to increase to 8 million adults by 2030. This disease is accompanied by a high mortality rate of 20-30%, and a high rehospitalization rate. To this end, the ACC/AHA/HFSA issued a focused guideline update on HF in 2016 in light of two new, FDA-approved therapies: valsartan/sacubitril, an angiotensin receptor-neprilysin inhibitor (ARNI), and ivabradine, a sinoatrial node modulator. An expert faculty panel will help drive an interactive symposium at CRT where the audience will be asked to participate in order to reach a consensus on how best to: implement new guidance into clinical practice, optimize therapy strategies, and coordinate care to improve patient outcomes in HF.
Upon completion of this activity, participants will be able to:
• Explore current evidence-based guideline recommendations for pharmacological management of heart failure
• Interpret recent clinical trial findings with new therapies for heart failure
• Formulate appropriate heart failure therapeutic strategies based on the patient’s disease status and other related diagnostic factors, comorbidities, and individual needs
• Discuss the importance of care coordination and transition for improving clinical outcomes in patients with heart failure
• Explore current evidence-based guideline recommendations for pharmacological management of heart failure
• Interpret recent clinical trial findings with new therapies for heart failure
• Formulate appropriate heart failure therapeutic strategies based on the patient’s disease status and other related diagnostic factors, comorbidities, and individual needs
• Discuss the importance of care coordination and transition for improving clinical outcomes in patients with heart failure
This activity is sponsored by the Academy for Continued Healthcare Learning.
1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.
2. Compatible with Windows PC and MAC (256 MB of RAM or higher)
3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher
4. Adobe Flash Player 12.0 (or higher).
5. Adobe Reader to print certificate.
6. Allow ActiveX controls to run on your computer: If the yellow strip appears on the top of your web browser while running the Webcast, right click on it and select Allow blocked contents to run.
7. Turn the Pop-up blocker off: On the Tools menu, point to Pop-up Blocker, and then click Turn Off Pop-up Blocker.
2. Compatible with Windows PC and MAC (256 MB of RAM or higher)
3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher
4. Adobe Flash Player 12.0 (or higher).
5. Adobe Reader to print certificate.
6. Allow ActiveX controls to run on your computer: If the yellow strip appears on the top of your web browser while running the Webcast, right click on it and select Allow blocked contents to run.
7. Turn the Pop-up blocker off: On the Tools menu, point to Pop-up Blocker, and then click Turn Off Pop-up Blocker.
Welcome and Patient Case Introduction with Navin Kapur, MD
Guidelines for the Management of Heart Failure with Ileana Piña, MD, MPH
Regimen Optimization and Individualized Strategies with Peter Carson, MD
Care Coordination and Transition to Improve Heart Failure Outcomes with Navin Kapur, MD
Guidelines for the Management of Heart Failure with Ileana Piña, MD, MPH
Regimen Optimization and Individualized Strategies with Peter Carson, MD
Care Coordination and Transition to Improve Heart Failure Outcomes with Navin Kapur, MD
Peter Carson, MD
Professor of Medicine
Georgetown University
Chief, Coronary Care Unit
Washington VA Medical Center
Washington, DC
Professor of Medicine
Georgetown University
Chief, Coronary Care Unit
Washington VA Medical Center
Washington, DC
Navin K. Kapur, MD
Associate Professor of Medicine
Executive Director of Research and Innovation
The Cardiovascular Center at Tufts Medical Center
Boston, MA
Ileana L. Piña, MD, MPH
Professor of Medicine
Professor of Epidemiology and Population Health
Director of Cardiology
Montefiore Medical Center
Bronx, NY
The Academy for Continued Healthcare Learning (ACHL) requires that the faculty participating in a CME/CE activity disclose all affiliations or other financial relationships (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the activity. All conflicts of interest have been resolved prior to this CME/CE activity.
The following financial relationships have been provided:
Peter Carson, MD
Committee Member: Novartis Pharmaceuticals Corporation
Navin Kapur, MD
Consulting: Abiomed, Boston Scientific Corporation, Cardiac Assist, HeartWare, St. Jude Medical/Thoratec
Sources of Funding for Research: Abiomed, Boston Scientific Corporation, Cardiac Assist, HeartWare, St. Jude Medical/Thoratec
Speaker: Abiomed, Boston Scientific Corporation, Cardiac Assist, HeartWare, St. Jude Medical/Thoratec
Ileana Piña, MD, MPH
Nothing to Disclose
Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: None
ACHL staff members and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.
The content for this activity was developed independently of the commercial supporter. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher or grantor.
This educational activity was planned and produced in accordance with the ACCME Accreditation Criteria, Policies, and Standards for Commercial Support. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.
This CME/CE activity might describe the off-label, investigational, or experimental use of medications that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. ACHL requires the speaker to disclose that a product is not labeled for the use under discussion.
This activity will take approximately 60 minutes to complete. To receive credit, participants are required to complete the pre-test, view the online webinar and complete the post-test and evaluation forms. To receive credit, 66% must be achieved on the post-test. A certificate will be immediately available. There is no fee to participate in the activity or for the generation of the certificate. Inquiries may be directed to ACHL at (877) 444-8435, ext. 205.
The Academy for Continued Healthcare Learning is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Academy for Continued Healthcare Learning designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.